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The prevalence of gestational diabetes mellitus (GDM) in the United States is increasing, 
and rates in some populations range from 3 to 14%.1–3 The true prevalence of GDM may be 
even higher because underreporting of GDM on birth certificates is well documented.1–4 
Difficulties in documenting and reaching consensus on the prevalence of GDM exist for a 
number of reasons, including the use of various diagnostic criteria, past confusion about the 
specific criteria used to diagnose GDM, and the lack of a universal recommendation for 
screening and diagnosis.5,6
In previous publications, 5–7 researchers have outlined and critiqued the various GDM 
guidelines established by professional organizations. Most agree on assessment of the risk 
for GDM for all pregnant women, with the exception of the U.S. Preventive Service Task 
Force.8 However, they differ on testing procedures, diagnostic criteria, target blood glucose 
levels during pregnancy, and scheduled postpartum testing and follow-up for diabetes.5,6
A lack of consensus regarding screening for and diagnosing GDM is concerning because it 
can be a barrier for health care providers (HCPs) in diagnosing and documenting GDM in 
medical records and on birth certificates. Appropriate documentation of GDM in hospital 
and prenatal care records and on birth certificates would increase identification of women at 
risk for type 2 diabetes and facilitate outreach by HCPs to ensure that they receive the 
information and resources needed to help prevent the development of diabetes in the future.9
This article describes intervention efforts and the results of a pilot project called The GDM 
Collaborative: Better Data, Better Care that are being funded by the Centers for Disease 
Control and Prevention in collaboration with the National Association of Chronic Disease 
Directors and the National Association of Maternal and Child Health Programs. The GDM 
Collaborative was developed to establish a multistate program to:
• Identify, catalog, and validate routinely collected GDM prevalence data;
• Identify gaps in the quality of GDM prevalence data and documented care;
• Develop interventions to improve access to care and increase postpartum follow-up 
for women with a history of GDM; and
• Enhance collaborations among public health programs.
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In the initial phase of the program, five states participated in a validation project to assess 
the quality of GDM data in various datasets. Cross-comparisons were made using multiple 
sources of 2004 GDM data, including the Pregnancy Risk Assessment Monitoring System 
(PRAMS), birth certificates, medical records, hospital discharge data, and prenatal records.
PRAMS data are self-reported and were used to ascertain whether women identified 
themselves as having elevated blood glucose levels during their most recent pregnancy. On 
PRAMS, women were asked, “During your most recent pregnancy, did you have high blood 
sugar (diabetes) that started during this pregnancy?” Women who gave a positive response 
to this question were considered to have GDM. These data were then compared to birth 
certificates, hospital medical records, and prenatal chart records for 277 participants with a 
positive response to the PRAMS question to ascertain whether the GDM diagnosis was 
documented for each participant.
In brief, the results of this validation process revealed that a diagnosis of GDM was omitted 
from 38% of the 277 birth certificates reviewed, although the diagnosis was found in 62% of 
maternal medical records for corresponding patients. Twenty-six percent of the participants 
with risk factors for GDM lacked documented testing and/or follow-up for GDM, and 36% 
did not have an elevated glucose level or a GDM diagnosis. Only 50% of the medical 
records reviewed had the appropriate International Classification of Diseases, Ninth 
Revision (ICD-9) code (code 648.8) confirming the diagnosis of abnormal glucose tolerance 
during pregnancy. In addition, only 5% of all the medical charts reviewed documented 
follow-up postpartum glucose testing and care or referrals for preventive care.
The omission of a GDM diagnosis from birth certificates and missing information about 
abnormal glucose tolerance in maternal medical records can result in women with GDM 
going undetected by the health care system. This can affect whether women with GDM 
receive the necessary follow-up preventive care services to reduce their risk of developing 
type 2 diabetes.
Given these findings, the five states participating in the GDM Collaborative began 
developing a variety of interventions to improve the quality of GDM prevalence data and 
enhance provision of care for women with a history of GDM. Interventions from two 
participating states, West Virginia and Utah, are highlighted below.
Utah: Improving GDM Documentation in Medical Records
Concerned about GDM reporting discrepancies between birth certificates and PRAMS, the 
Utah GDM Collaborative team developed initiatives to identify reasons for these 
discrepancies. Maternal worksheets, completed in the hospital by mothers after delivery, 
were revised to include the 2009 version of the PRAMS question, which asked specifically 
about GDM (as opposed to asking about diabetes or high blood sugar). This question, 
“During your most recent pregnancy, were you told by a doctor, nurse, or other health care 
worker that you had gestational diabetes (diabetes that started during this pregnancy)?,” was 
added to alert medical records personnel to closely review the patient’s medical record chart 
for a GDM diagnosis to ensure accurate GDM data translation to the birth certificate.
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The Utah Office of Vital Records and Statistics implemented a training program for hospital 
staff transcribing medical record data to birth certificates to improve documentation of 
GDM on birth certificates. In 2010, Utah conducted a second validation review to determine 
whether GDM reporting had improved as a result of these changes. In this validation study 
(April to August 2010), 445 maternal worksheets had self-reported cases of GDM, but only 
77% had a GDM diagnosis reported on the birth certificate. This is a 15% increase of 
confirmed GDM cases compared to the initial validation; however, a discrepancy exists 
given that 23% of the women reported GDM on their maternal worksheets but had no such 
diagnosis documented on their child’s birth certificate or in the medical records.
The Utah GDM Collaborative team conducted a medical record review for those worksheets 
(n = 100) that had self-reported GDM but no indication of GDM on the birth certificate. This 
review was conducted to determine where discrepancies existed to validate diagnosis and to 
ascertain the reasons for these discrepancies.
A GDM diagnosis was confirmed on 58 medical records, but the diagnosis could not be 
confirmed on the remaining 42 charts. Reasons for discrepancies included 1) patient 
misunderstanding her condition, reporting GDM when she actually had preexisting type 2 
diabetes; 2) patient had a history of GDM in a prior pregnancy but not during the one under 
review; and 3) patient had an elevated glucose level that was insufficient for a diagnosis of 
GDM (e.g., high 1-hour screening results, but normal 2- or 3-hour results).
Only 26 (44.8%) of the confirmed GDM cases had ICD-9 code 648.8 documented. Failures 
in ICD coding procedures may result in inadequate patient discharge education and referral 
and, ultimately, in inaccurate hospital discharge data. The Utah GDM Collaborative team 
concluded that, although discrepancies existed in documenting GDM between maternal 
worksheets and birth certificates and medical records, the maternal worksheets are useful as 
a flag for medical records personnel to research further to ascertain a confirmed diagnosis 
for birth certificates and diagnosis coding.
To improve GDM care, various interventions are needed. Based on the above-mentioned 
findings, Utah’s Office of Vital Records and Statistics will intervene by continuing to 
conduct annual training for medical records personnel to improve GDM reporting. The 
training teaches clerks to accurately review maternal worksheets and ensure that if GDM is 
listed on the worksheet it is also documented on the birth certificate and confirmed in the 
medical record.
At the patient level, it appears that some of the discrepancies found in these data may result 
from women not understanding what GDM is. As stated earlier, some of the women who 
had preexisting diabetes self-reported erroneously that they had GDM. Diabetes educators 
could assist such women in better understanding their condition and communicating their 
health history and health care needs to HCPs.
West Virginia: Developing GDM Interventions in an Outpatient Clinic
Implemented in a tertiary care outpatient clinic, West Virginia’s interventions focused on 
developing a system to improve the identification and care of women with GDM, with an 
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emphasis on increasing postpartum follow-up testing. The three aims were to 1) establish a 
process for identifying and documenting GDM, 2) educate women with GDM during the 
prenatal period about reducing the risk of type 2 diabetes, and 3) improve postpartum blood 
glucose testing.
An interdisciplinary team consisting of clinical and public health practitioners and research 
staff focused on implementing a variety of strategies to meet the above-mentioned aims of 
the project. These strategies included 1) providing GDM education for all clinic staff 
regarding GDM screening guidelines, the diagnosis algorithm, follow-up and postpartum 
care, marking and labeling charts appropriately, pulling charts, and using a postpartum 
checklist; 2) standardizing clinic procedures for screening and documenting GDM; 3) 
providing type 2 diabetes risk education during prenatal visits; 4) scheduling postpartum 
visits with glucose testing orders before discharge; 5) performing glucose testing in the 
clinic during the postpartum visit; and 6) referring women with GDM to the clinic’s 
Diabetes Center for education classes that focused on nutrition, self-monitoring, and 
physical activity.
After 1 year, comparison of baseline and current clinic data showed improvements in 
severalareas. Compliance with screening for GDM (using a 1-hour, 50-g oral glucose 
challenge test and, if failed, then a 3-hour, 100-g glucose tolerance test) improved from 55% 
at baseline to 73% at 1 year. A GDM diagnosis was documented on 100% of the patients’ 
charts. Attendance at postpartum visits increased from 50 to 89%. Postpartum laboratory test 
orders for glucose testing increased from 10% at baseline to 39% at 1 year. The researchers 
also evaluated whether the number of women who received GDM education increased over 
time. At baseline, 73% of the charts included documented GDM education. At 1 year, 
documented GDM education increased to 95%, a relative improvement of 30% over 
baseline.
This assessment indicates that changing and standardizing the clinic processes for 
identification and care for women with GDM improved screening, documentation, and 
follow-up for GDM. The team continues to monitor the processes with a focus on sustaining 
changes and, if necessary, intervening to remove any barriers that may impede the provision 
of care for women with GDM.
Conclusion
GDM is a strong predictor of type 2 diabetes in women, but far too many women who 
develop this condition are not receiving the care needed to help them prevent or delay their 
progression to type 2 diabetes. An important step to reach women with GDM is to improve 
public health surveillance. This is crucial for accurate documentation, outreach, patient 
education, and timely intervention.
The initial findings from these two sites suggest that gaps exist in our current surveillance 
system and that there is a need for better data sources and quality improvement processes to 
improve outreach to women with a history of GDM for postpartum and long-term care. Data 
from West Virginia’s project also suggest that making system changes in clinical practices 
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and documentation can also improve the quality of GDM care. Replication of these 
interventions in other states is needed to determine whether similar gaps exist in state-
specific GDM data and how these gaps affect the provision and receipt of postpartum care.
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